ORIENT BIO Inc. (002630.KS)
KRW 967.0
(-14.65%)
KRW 967.0
(-14.65%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 108.55 KRW | 167.7% |
| 2022 | -104.78 KRW | -696.81% |
| 2021 | -13.15 KRW | 90.48% |
| 2020 | -138.07 KRW | -30.97% |
| 2019 | -105.42 KRW | 58.07% |
| 2018 | -251.44 KRW | -203.41% |
| 2017 | -82.87 KRW | 28.99% |
| 2016 | -116.70 KRW | -154.08% |
| 2015 | -45.93 KRW | -208.26% |
| 2014 | -14.90 KRW | 83.33% |
| 2013 | -89.39 KRW | -1438.17% |
| 2012 | 6.68 KRW | 106.24% |
| 2011 | -107.00 KRW | -358.33% |
| 2010 | 41.42 KRW | 842.29% |
| 2009 | -5.58 KRW | 22.18% |
| 2008 | -7.17 KRW | 90.32% |
| 2007 | -74.08 KRW | -945.66% |
| 2006 | 8.76 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -57.22 KRW | -203.89% |
| 2023 Q4 | 55.08 KRW | 2960.0% |
| 2023 Q3 | 1.80 KRW | 132.85% |
| 2023 FY | - KRW | 167.7% |
| 2023 Q1 | 19.54 KRW | 353.36% |
| 2023 Q2 | -5.48 KRW | -128.05% |
| 2022 Q2 | 73.28 KRW | 197.36% |
| 2022 FY | - KRW | -696.81% |
| 2022 Q4 | 4.31 KRW | 104.02% |
| 2022 Q3 | -107.11 KRW | -246.17% |
| 2022 Q1 | -75.27 KRW | 0.0% |
| 2021 Q3 | 8.00 KRW | 530.11% |
| 2021 FY | - KRW | 90.48% |
| 2021 Q1 | 22.69 KRW | 125.92% |
| 2021 Q2 | -1.86 KRW | -108.2% |
| 2020 Q4 | -87.54 KRW | -357.47% |
| 2020 FY | - KRW | -30.97% |
| 2020 Q1 | -4.00 KRW | 84.91% |
| 2020 Q2 | -81.00 KRW | -1925.0% |
| 2020 Q3 | 34.00 KRW | 141.98% |
| 2019 Q1 | -8.80 KRW | 92.87% |
| 2019 FY | - KRW | 58.07% |
| 2019 Q3 | -8.98 KRW | 93.55% |
| 2019 Q2 | -139.19 KRW | -1481.7% |
| 2019 Q4 | -26.50 KRW | -195.1% |
| 2018 FY | - KRW | -203.41% |
| 2018 Q3 | 15.00 KRW | 132.66% |
| 2018 Q4 | -123.50 KRW | -923.33% |
| 2018 Q1 | -19.27 KRW | -19.32% |
| 2018 Q2 | -45.93 KRW | -138.35% |
| 2017 FY | - KRW | 28.99% |
| 2017 Q2 | -30.83 KRW | -299.87% |
| 2017 Q3 | -27.94 KRW | 9.37% |
| 2017 Q1 | -7.71 KRW | 26.08% |
| 2017 Q4 | -16.15 KRW | 42.2% |
| 2016 FY | - KRW | -154.08% |
| 2016 Q2 | -6.49 KRW | 93.75% |
| 2016 Q3 | -127.63 KRW | -1866.56% |
| 2016 Q4 | -10.43 KRW | 91.83% |
| 2016 Q1 | -103.83 KRW | -258.9% |
| 2015 Q1 | -9.64 KRW | 21.5% |
| 2015 Q4 | -28.93 KRW | -528.59% |
| 2015 Q3 | 6.75 KRW | 216.78% |
| 2015 FY | - KRW | -208.26% |
| 2015 Q2 | -5.78 KRW | 40.04% |
| 2014 Q3 | -6.13 KRW | -333.08% |
| 2014 Q1 | -1.75 KRW | 96.2% |
| 2014 FY | - KRW | 83.33% |
| 2014 Q2 | 2.63 KRW | 250.29% |
| 2014 Q4 | -12.28 KRW | -100.33% |
| 2013 Q2 | -22.79 KRW | -116.63% |
| 2013 FY | - KRW | -1438.17% |
| 2013 Q4 | -46.04 KRW | -651.06% |
| 2013 Q3 | -6.13 KRW | 73.1% |
| 2013 Q1 | -10.52 KRW | -3.54% |
| 2012 FY | - KRW | 106.24% |
| 2012 Q2 | 0.80 KRW | -83.26% |
| 2012 Q3 | 14.34 KRW | 1692.5% |
| 2012 Q4 | -10.16 KRW | -170.85% |
| 2012 Q1 | 4.78 KRW | -90.67% |
| 2011 Q3 | 2.39 KRW | 102.27% |
| 2011 Q2 | -105.22 KRW | -4502.51% |
| 2011 Q4 | 51.25 KRW | 2044.35% |
| 2011 Q1 | 2.39 KRW | 104.98% |
| 2011 FY | - KRW | -358.33% |
| 2010 Q4 | -47.95 KRW | -162.06% |
| 2010 Q1 | 0.80 KRW | 116.13% |
| 2010 Q2 | -7.97 KRW | -1096.25% |
| 2010 Q3 | 77.26 KRW | 1069.39% |
| 2010 FY | - KRW | 842.29% |
| 2009 Q1 | 4.78 KRW | 132.12% |
| 2009 Q2 | 23.90 KRW | 400.0% |
| 2009 Q3 | -11.95 KRW | -150.0% |
| 2009 Q4 | -4.96 KRW | 58.49% |
| 2009 FY | - KRW | 22.18% |
| 2008 Q1 | 6.37 KRW | 11.56% |
| 2008 Q3 | 0.80 KRW | 0.0% |
| 2008 Q4 | -14.88 KRW | -1960.0% |
| 2008 FY | - KRW | 90.32% |
| 2008 Q2 | 0.80 KRW | -87.44% |
| 2007 Q4 | 5.71 KRW | -21.89% |
| 2007 FY | - KRW | -945.66% |
| 2007 Q1 | -31.83 KRW | 0.0% |
| 2007 Q3 | 7.31 KRW | 113.3% |
| 2007 Q2 | -54.96 KRW | -72.67% |
| 2006 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Green Cross Holdings Corporation | -1210.00 KRW | 108.971% |
| Green Cross Holdings Corporation | -2333.42 KRW | 104.652% |
| Pharmicell Co., Ltd. | 60.00 KRW | -80.917% |
| Green Cross Corporation | -2333.42 KRW | 104.652% |
| GeneOne Life Science, Inc. | -1000.23 KRW | 110.853% |
| Celltrion, Inc. | 3759.00 KRW | 97.112% |
| Samsung Biologics Co.,Ltd. | 12.05 Thousand KRW | 99.099% |
| SK bioscience Co.,Ltd. | 291.00 KRW | 62.698% |
| SK Biopharmaceuticals Co., Ltd. | -419.89 KRW | 125.852% |
| Prestige BioPharma Limited | -547.81 KRW | 119.815% |